成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)-

nicocodine Struktur
3688-66-2
CAS-Nr.
3688-66-2
Bezeichnung:
7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)-
Englisch Name:
nicocodine
Synonyma:
RC-146;Lyopect;nicocodine;Codeine nicotinate;RYBGRHAWFUVMST-MJFIPZRTSA-N;Nicocodine (1.0 mg/mL in Acetonitrile);7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol nicotinate;7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol 3-pyridinecarboxylate;Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 6-(3-pyridinecarboxylate), (5α,6α)-
CBNumber:
CB6937263
Summenformel:
C24H24N2O4
Molgewicht:
404.47
MOL-Datei:
3688-66-2.mol

7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)- Eigenschaften

Schmelzpunkt:
134.5°C
Siedepunkt:
526.07°C (rough estimate)
Dichte
1.2314 (rough estimate)
Brechungsindex
1.6300 (estimate)
pka
7.78±0.40(Predicted)

Sicherheit

DEA Controlled Substances CSCN: 9309
CSA SCH: Schedule I
NARC: Yes

7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)- Chemische Eigenschaften,Einsatz,Produktion Methoden

7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3688-66-2(7,8-Didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol-3-pyridincarboxylat, (5 alpha,6 alpha)-)Verwandte Suche:

  • 7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol 3-pyridinecarboxylate
  • 7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol nicotinate
  • Codeine nicotinate
  • Lyopect
  • RC-146
  • nicocodine
  • RYBGRHAWFUVMST-MJFIPZRTSA-N
  • Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 6-(3-pyridinecarboxylate), (5α,6α)-
  • Nicocodine (1.0 mg/mL in Acetonitrile)
  • 3688-66-2
Copyright 2019 ? ChemicalBook. All rights reserved